← All trials
NCT02559791
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2015
- Primary completion
- Oct 1, 2016
- Completion date
- Oct 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- McMaster UniversityLead sponsor
- TevaCollaborator
- McMaster UniversityOverall official - principal investigator
- McMaster UniversityReponsible party - principal investigator
- University of Western OntarioCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.